Recruiting Follicular Lymphoma Studies in Chicago
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease...
A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subty...
A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
This study is planned as a single arm clinical trial of tazemetostat in combination with bendamustine and rituximab with both a phase I and phase II component. All patients will receive tazemetostat t...
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
The study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisti...
About Follicular Lymphoma Clinical Trials in Chicago
Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.
There are currently 4 follicular lymphoma clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 1,573 participants. Research is being sponsored by Genmab, AstraZeneca, Vaishalee Kenkre and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Follicular Lymphoma Clinical Trials in Chicago — FAQ
Are there follicular lymphoma clinical trials in Chicago?
Yes, there are 4 follicular lymphoma clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What follicular lymphoma treatments are being tested?
The 4 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov